CrossTalk opposing view: Most cardiovascular diseases in sleep apnoea are not caused by sympathetic activation

Journal of Physiology

Volumn 590, Issue 12, 2012, Pages 2817-2819

  Lavie, Lena ^a   Lavie, Peretz ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; ENDOTHELIN 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; REACTIVE OXYGEN METABOLITE;

ARTERIAL WALL THICKNESS; ARTERY DIAMETER; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CAROTID ARTERY; COMORBIDITY; DISEASE ASSOCIATION; ENDOTHELIAL DYSFUNCTION; HUMAN; HYPERTENSION; NONHUMAN; NOTE; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PULSE WAVE; SLEEP APNEA SYNDROME; SYMPATHETIC TONE;

ANIMALS; CARDIOVASCULAR DISEASES; HUMANS; SLEEP APNEA, OBSTRUCTIVE; SYMPATHETIC NERVOUS SYSTEM;

EID: 84862534304     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2012.233833     Document Type: Note

References (31)

1. Abdilla N, Tormo MC, Fabia MJ, Chaves FJ, Saez G & Redon J (2007). Impact of the components of metabolic syndrome on oxidative stress and enzymatic antioxidant activity in essential hypertension. J Hum Hypertens 21, 68-75.
2. Carlson JT, Hedner J, Elam M, Ejnell H, Sellgren J & Wallin BG (1993). Augmented resting sympathetic activity in awake patients with obstructive sleep apnea. Chest 103, 1763-1768.
3. Chan SH & Chan JY (2012). Angiotensin- generated reactive oxygen species in brain and pathogenesis of cardiovascular diseases. Antioxid Redox Signal; DOI:
4. B receptors by sympathetic neurons in DOCA-salt hypertensive rats. Hypertension 43, 1048-1054.
5. Danson EJ & Paterson DJ (2006). Reactive oxygen species and autonomic regulation of cardiac excitability. J Cardiovasc Electrophysiol 17 (Suppl. 1), S104-S112.
6. Datla SR & Griendling KK (2010). Reactive oxygen species, NADPH oxidases, and hypertension. Hypertension 56, 325-330.
7. Drager LF, Bortolotto LA, Lorenzi MC, Figueiredo AC, Krieger EM & Lorenzi-Filho G (2005). Early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med 172, 613-618.
8. Dyugovskaya L, Lavie P & Lavie L (2002). Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am J Respir Crit Care Med 165, 934-939.
9. Dyugovskaya L, Lavie P & Lavie L (2003). Phenotypic and functional characterization of blood γδ T cells in sleep apnea. Am J Respir Crit Care Med 168, 242-249.
10. Dyugovskaya L, Polyakov A, Ginsberg D, Lavie P & Lavie L (2011). Molecular pathways of spontaneous and TNF-α-mediated neutrophil apoptosis under intermittent hypoxia. Am J Respir Cell Mol Biol 45, 154-162.
11. Dyugovskaya L, Polyakov A, Lavie P & Lavie L (2008). Delayed neutrophil apoptosis in patients with sleep apnea. Am J Respir Crit Care Med 177, 544-554.
12. El Solh AA, Saliba R, Bosinski T, Grant BJ, Berbary E & Miller N (2006). Allopurinol improves endothelial function in sleep apnoea: a randomised controlled study. Eur Respir J 27, 997-1002.
13. Grebe M, Eisele HJ, Weissmann N, Schaefer C, Tillmanns H, Seeger W & Schulz R (2006). Antioxidant vitamin C improves endothelial function in obstructive sleep apnea. Am J Respir Crit Care Med 173, 897-901.
14. Hirooka Y (2011). Oxidative stress in the cardiovascular center has a pivotal role in the sympathetic activation in hypertension. Hypertens Res 34, 407-412.
15. Htoo AK, Greenberg H, Tongia S, Chen G, Henderson T, Wilson D & Liu SF (2006). Activation of nuclear factor κB in obstructive sleep apnea: a pathway leading to systemic inflammation. Sleep Breath 10, 43-50.
16. Jelic S, Padeletti M, Kawut SM, Higgins C, Canfield SM, Onat D, Colombo PC, Basner RC, Factor P & LeJemtel TH (2008). Inflammation, oxidative stress, and repair capacity of the vascular endothelium in obstructive sleep apnea. Circulation 117, 2270-2278.
17. Kato M, Roberts-Thomson P, Phillips BG, Haynes WG, Winnicki M, Accurso V & Somers VK (2000). Impairment of endothelium-dependent vasodilation of resistance vessels in patients with obstructive sleep apnea. Circulation 102, 2607-2610.
18. Kimura Y, Hirooka Y, Sagara Y, Ito K, Kishi T, Shimokawa H, Takeshita A & Sunagawa K (2005). Overexpression of inducible nitric oxide synthase in rostral ventrolateral medulla causes hypertension and sympathoexcitation via an increase in oxidative stress. Circ Res 96, 252-260.
19. Kumar GK, Rai V, Sharma SD, Ramakrishnan DP, Peng YJ, Souvannakitti D & Prabhakar NR (2006). Chronic intermittent hypoxia induces hypoxia-evoked catecholamine efflux in adult rat adrenal medulla via oxidative stress. J Physiol 575, 229-239.
20. Lavie L (2003). Obstructive sleep apnoea syndrome-an oxidative stress disorder. Sleep Med Rev 7, 35-51.
21. Lavie L, Hefetz A, Luboshitzky R & Lavie P (2003). Plasma levels of nitric oxide and L-arginine in sleep apnea patients: effects of nCPAP treatment. J Mol Neurosci 21, 57-63.
22. Lavie L & Lavie P (2009). Molecular mechanisms of cardiovascular disease in OSAHS: the oxidative stress link. Eur Respir J 33, 1467-1484.
23. Lee MY & Griendling KK (2008). Redox signaling, vascular function, and hypertension. Antioxid Redox Signal 10, 1045-1059.
24. Lob HE, Marvar PJ, Guzik TJ, Sharma S, McCann LA, Weyand C, Gordon FJ & Harrison DG (2010). Induction of hypertension and peripheral inflammation by reduction of extracellular superoxide dismutase in the central nervous system. Hypertension 55, 277-283, 6p following 283.
25. Moller DS, Lind P, Strunge B & Pedersen EB (2003). Abnormal vasoactive hormones and 24-hour blood pressure in obstructive sleep apnea. Am J Hypertens 16, 274-280.
26. Peng YJ, Nanduri J, Khan SA, Yuan G, Wang N, Kinsman B, Vaddi DR, Kumar GK, Garcia JA, Semenza GL & Prabhakar NR (2011). Hypoxia-inducible factor 2α (HIF-2α) heterozygous-null mice exhibit exaggerated carotid body sensitivity to hypoxia, breathing instability, and hypertension. Proc Natl Acad Sci U S A 108, 3065-3070.
27. Peng YJ, Yuan G, Ramakrishnan D, Sharma SD, Bosch-Marce M, Kumar GK, Semenza GL & Prabhakar NR (2006). Heterozygous HIF-1α deficiency impairs carotid body-mediated systemic responses and reactive oxygen species generation in mice exposed to intermittent hypoxia. J Physiol 577, 705-716.
28. Schulz E, Gori T & Munzel T (2011). Oxidative stress and endothelial dysfunction in hypertension. Hypertens Res 34, 665-673.
29. Shokoji T, Nishiyama A, Fujisawa Y, Hitomi H, Kiyomoto H, Takahashi N, Kimura S, Kohno M & Abe Y (2003). Renal sympathetic nerve responses to tempol in spontaneously hypertensive rats. Hypertension 41, 266-273.
30. Somers VK, White DP, Amin R, Abraham WT, Costa F, Culebras A, Daniels S, Floras JS, Hunt CE, Olson LJ, Pickering TG, Russell R, Woo M & Young T (2008). Sleep apnea and cardiovascular disease: an American Heart Association/American College Of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council On Cardiovascular Nursing. In collaboration with the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health). Circulation 118, 1080-1111.
31. Troncoso Brindeiro CM, da Silva AQ, Allahdadi KJ, Youngblood V & Kanagy NL (2007). Reactive oxygen species contribute to sleep apnea-induced hypertension in rats. Am J Physiol Heart Circ Physiol 293, H2971-H2976.